Connection

Susan Sonne to Humans

Back to Details
This is a "connection" page, showing publications Susan Sonne has written about Humans.
Susan Sonne
Connection Strength
0.273
Humans
  1. Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review: A CTSA Institution's Experience. J Empir Res Hum Res Ethics. 2018 04; 13(2):139-144.
    View in: PubMed
    Score: 0.023
  2. Response to Commentary: Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review-A CTSA Institution's Experience. J Empir Res Hum Res Ethics. 2018 04; 13(2):148.
    View in: PubMed
    Score: 0.023
  3. Development and pilot testing of a video-assisted informed consent process. Contemp Clin Trials. 2013 Sep; 36(1):25-31.
    View in: PubMed
    Score: 0.017
  4. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict. 2010 Mar-Apr; 19(2):111-8.
    View in: PubMed
    Score: 0.013
  5. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005 Dec; 3(1):13-21.
    View in: PubMed
    Score: 0.010
  6. Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. 2003 Oct-Dec; 12(5):412-23.
    View in: PubMed
    Score: 0.009
  7. Alcohol and substance abuse. Med Clin North Am. 2001 May; 85(3):779-801.
    View in: PubMed
    Score: 0.007
  8. Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021 01 14; 384(2):140-153.
    View in: PubMed
    Score: 0.007
  9. Oral nutritional supplementation for the alcoholic patient: a brief overview. Ann Clin Psychiatry. 2000 Sep; 12(3):153-8.
    View in: PubMed
    Score: 0.007
  10. Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence. J Clin Psychopharmacol. 2000 Feb; 20(1):114-5.
    View in: PubMed
    Score: 0.007
  11. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.007
  12. Substance abuse and bipolar comorbidity. Psychiatr Clin North Am. 1999 Sep; 22(3):609-27, ix.
    View in: PubMed
    Score: 0.007
  13. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
    View in: PubMed
    Score: 0.006
  14. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health. 1999; 23(4):263-71.
    View in: PubMed
    Score: 0.006
  15. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
    View in: PubMed
    Score: 0.006
  16. Diagnosis of personality disorders in cocaine-dependent individuals. Am J Addict. 1998; 7(1):1-6.
    View in: PubMed
    Score: 0.006
  17. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.006
  18. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.006
  19. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
    View in: PubMed
    Score: 0.006
  20. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
    View in: PubMed
    Score: 0.005
  21. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22.
    View in: PubMed
    Score: 0.005
  22. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence. J Subst Abuse Treat. 2015 Oct; 57:70-4.
    View in: PubMed
    Score: 0.005
  23. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry. 1995; 56 Suppl 3:19-24.
    View in: PubMed
    Score: 0.005
  24. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
    View in: PubMed
    Score: 0.005
  25. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994 Jun; 182(6):349-52.
    View in: PubMed
    Score: 0.005
  26. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. J Clin Psychiatry. 2014 Apr; 75(4):336-43.
    View in: PubMed
    Score: 0.004
  27. A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend. 2013 Dec 15; 133(3):845-51.
    View in: PubMed
    Score: 0.004
  28. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):112-8.
    View in: PubMed
    Score: 0.004
  29. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46.
    View in: PubMed
    Score: 0.004
  30. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):455-63.
    View in: PubMed
    Score: 0.004
  31. Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):472-8.
    View in: PubMed
    Score: 0.004
  32. Improving the transition from residential to outpatient addiction treatment: gender differences in response to supportive telephone calls. Am J Drug Alcohol Abuse. 2008; 34(1):47-59.
    View in: PubMed
    Score: 0.003
  33. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008 Jul; 35(1):68-77.
    View in: PubMed
    Score: 0.003
  34. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006 Sep; 194(9):690-6.
    View in: PubMed
    Score: 0.003
  35. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006 May; 78(5):759-769.
    View in: PubMed
    Score: 0.003
  36. Alcohol dependence and posttraumatic stress disorder: differences in clinical presentation and response to cognitive-behavioral therapy by order of onset. J Subst Abuse Treat. 2005 Jul; 29(1):29-37.
    View in: PubMed
    Score: 0.002
  37. Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study. BMC Med Res Methodol. 2005 Mar 30; 5:11.
    View in: PubMed
    Score: 0.002
  38. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401.
    View in: PubMed
    Score: 0.002
  39. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry. 2004 Jul-Aug; 45(4):304-10.
    View in: PubMed
    Score: 0.002
  40. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
    View in: PubMed
    Score: 0.002
  41. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
    View in: PubMed
    Score: 0.002
  42. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
    View in: PubMed
    Score: 0.002
  43. Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
    View in: PubMed
    Score: 0.002
  44. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001 Feb; 21(1):116-8.
    View in: PubMed
    Score: 0.002
  45. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001; 14(4):255-62.
    View in: PubMed
    Score: 0.002
  46. Valproate for alcoholics with bipolar disorder. Am J Psychiatry. 1999 Jul; 156(7):1122.
    View in: PubMed
    Score: 0.002
  47. Posttraumatic stress disorder and cocaine dependence. Order of onset. Am J Addict. 1998; 7(2):128-35.
    View in: PubMed
    Score: 0.001
  48. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry. 1995 Nov; 56(11):502-5.
    View in: PubMed
    Score: 0.001
  49. Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother. 1995 Apr; 29(4):387-95.
    View in: PubMed
    Score: 0.001
  50. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21.
    View in: PubMed
    Score: 0.001
  51. Fluoxetine-associated side effects and suicidality. J Clin Psychopharmacol. 1993 Aug; 13(4):292-5.
    View in: PubMed
    Score: 0.001
  52. Lithium side effects in the medically ill. Int J Psychiatry Med. 1993; 23(4):357-82.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.